Russell Investments Group
HCAT icon

Russell Investments Group’s Health Catalyst HCAT Stock Holding History

Russell Investments Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05K Sell
2,538
-3,444
-58% -$4.97K ﹤0.01% 4036
2026
Q1 		$7.6K Buy
5,982
+267
+5% +$502 ﹤0.01% 3838
2025
Q4 		$13.7K Sell
5,715
-1,151
-17% -$3.15K ﹤0.01% 3721
2025
Q3 		$19.6K Buy
6,866
+6,817
+13,912% +$23.3K ﹤0.01% 3593
2025
Q2 		$185 Sell
49
-13,406
-100% -$52.7K ﹤0.01% 3793
2025
Q1 		$61K Sell
13,455
-64,835
-83% -$343K ﹤0.01% 2861
2024
Q4 		$554K Buy
78,290
+62,216
+387% +$496K ﹤0.01% 2246
2024
Q3 		$131K Sell
16,074
-60,229
-79% -$435K ﹤0.01% 2595
2024
Q2 		$488K Buy
76,303
+30,455
+66% +$195K ﹤0.01% 2209
2024
Q1 		$345K Buy
45,848
+64
+0.1% +$584 ﹤0.01% 2322
2023
Q4 		$424K Sell
45,784
-8,915
-16% -$72.9K ﹤0.01% 2274
2023
Q3 		$554K Sell
54,699
-15,101
-22% -$180K ﹤0.01% 2199
2023
Q2 		$872K Sell
69,800
-20,800
-23% -$248K ﹤0.01% 2004
2023
Q1 		$1.06M Sell
90,600
-27,010
-23% -$344K ﹤0.01% 1936
2022
Q4 		$1.25M Buy
117,610
+79,510
+209% +$768K ﹤0.01% 1861
2022
Q3 		$368K Buy
38,100
+17,396
+84% +$230K ﹤0.01% 2354
2022
Q2 		$300K Buy
+20,704
New +$353K ﹤0.01% 2434
2021
Q3 		– Sell
-8,185
Closed -$454K – 3109
2021
Q2 		$454K Buy
8,185
+5,121
+167% +$273K ﹤0.01% 2633
2021
Q1 		$143K Buy
+3,064
New +$148K ﹤0.01% 2908
2020
Q4 		– Sell
-3,757
Closed -$137K – 3108
2020
Q3 		$137K Hold
3,757
– – ﹤0.01% 2911
2020
Q2 		$109K Buy
+3,757
New +$104K ﹤0.01% 2867

Other funds holding HCAT

NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.89B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return

Russell Investments Group's HCAT Position: Q2 2026 in Review

Russell Investments Group reduced its Health Catalyst (HCAT) stake by 58% in Q2 2026, selling an estimated $4.97K and leaving 2,538 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4036.

Russell Investments Group first reported a position in HCAT in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.25M in Q4 2022. 49 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Russell Investments Group held 2,538 shares of Health Catalyst worth $5.05K as of Q2 2026.
  • Russell Investments Group sold 3,444 Health Catalyst shares in Q2 2026, an estimated $4.97K.
  • Health Catalyst made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4036 holding.
  • Russell Investments Group first reported a position in Health Catalyst in Q2 2020 and has held it in 21 quarters since.
  • Russell Investments Group's Health Catalyst position peaked at $1.25M in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.